Opinion|Videos|January 26, 2026

Role of APPs in the Delivery of Anti-Amyloid Therapies

Panelists discuss how APPs oversee and streamline the safe delivery of anti-amyloid Alzheimer therapies.

Panelists discuss how advanced practice providers (APPs) coordinate the logistical aspects of anti-amyloid therapy delivery, including imaging, infusion scheduling, and follow-up visits. Their organizational role ensures smooth transitions and minimizes patient disruption.

Panelists discuss how effective monitoring protocols—covering infusion reactions, laboratory testing, and symptom tracking—are essential for patient safety. APPs’ consistent communication with patients fosters adherence and early issue detection.

Panelists discuss how this coordination enhances system efficiency and strengthens patient confidence in complex treatment regimens. The segment highlights APPs as operational anchors within multidisciplinary teams delivering cutting-edge Alzheimer care.

Newsletter

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.

Brand Logo

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

609-716-7777

© 2025 MJH Life Sciences®

All rights reserved.

Secondary Brand Logo